Search

Displaying results 8951 - 8960 of 10000 in total
  1. Drug

    Nelutroctiv

    go.drugbank.com/drugs/DB21554
    Investigational

    Nelutroctiv is a small molecule drug. Nelutroctiv is under investigation in clinical trial NCT05662215 (A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants).

  2. Drug

    Cortivazol

    go.drugbank.com/drugs/DB13003
    Investigational

    Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection (CHCI)).

  3. Drug

    Stibophen

    go.drugbank.com/drugs/DB13236
    Experimental

    Stibophen is used in the treatment of schistosomiasis, a disease of parasitic flatworms.

  4. Drug

    Formononetin

    go.drugbank.com/drugs/DB15335
    Experimental

    Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.).

  5. Drug

    INO-4995

    go.drugbank.com/drugs/DB17834
    Experimental

    INO-4995 is an inositol tetrakisphosphate analog being investigated for Cystic Fibrosis.[A259781]

  6. Drug

    Novolimus

    go.drugbank.com/drugs/DB19085
    Investigational

    Novolimus is under investigation in clinical trial NCT04483791 (Dynamx Bioadaptor Hong Kong Registry).

  7. Drug

    Lixudebart

    go.drugbank.com/drugs/DB19244
    Investigational

    Lixudebart, an investigational first-in-class monoclonal antibody, aims to reverse fibrosis.[L50833]

  8. Drug

    Clinofibrate

    go.drugbank.com/drugs/DB09006
    Experimental

    Clinofibrate is a fibrate drug sold and marketed in Japan.

  9. Drug

    NP-6A4

    go.drugbank.com/drugs/DB17599
    Experimental

    NP-6A4 is a peptide designed to specifically bind and activate angiotensin II receptor type 2 (AT2R). It has an Orphan Drug designation from the FDA for pediatric cardiomyopathy.[A258523]

  10. Drug

    AZD8630

    go.drugbank.com/drugs/DB19397
    Investigational

    AZD8630 is an experimental drug under investigation, as described in the Phase I clinical study titled "Randomised, Blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics